CFDA issued the first birth certificate of "Viagra" in China, Baiyunshan "Jinge" got the production approval

Baiyunshan said that the company received the approval document for supplementary application of "sildenafil citrate" and "sildenafil citrate tablets" issued by the State Food and Drug Administration today The application for the production registration approval of "sildenafil citrate" API and tablet declared by the company has been approved by the State Food and drug administration, and the drug approval numbers are "gyzz h20143277" and "gyzz h20143255", respectively It is reported that this is the first birth certificate of "Viagra" issued by the State Food and drug administration Announcement of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd on obtaining "Jinge" drug production approval document announcement of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd on obtaining "Jinge" drug production approval document The company and all members of the board of directors guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and integrity of its contents This is to refer to the announcement of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd (the "company") on the progress of the production approval application of "sildenafil citrate" under the trade name of "Jinge" on July 31, 2014 and August 22, 2014 On September 2, 2014, the company obtained the approval document for supplementary drug application of "sildenafil citrate" and "sildenafil citrate tablets" issued by the State Food and drug administration The application for the production registration approval of "sildenafil citrate" API and tablet declared by the company has been approved by the State Food and drug administration, and the drug approval numbers are respectively "gyzz h20143277" and "gyzz h20143255" The company will promote relevant work as soon as possible, and realize the production and listing of Baiyunshan "Jinge" as soon as possible The information of the company shall be disclosed by the designated disclosure media Shanghai Securities Journal, securities times, China Securities Journal, Securities Daily, website of Shanghai Stock Exchange (http:// and website of Hong Kong Stock Exchange Co., Ltd (http:// Please pay attention to the risk and make rational investment It is hereby announced The board of directors of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd September 2, 2014